Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies.
Times cited: 8
- The efficacy of anti-PD-1 agents in acral and mucosal melanoma. Cancer. 2016 Academic Article GET IT
- Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.
Times cited: 59
Ipilimumab for patients with advanced mucosal melanoma.
Times cited: 46